By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Selexis SA 

177 Post Street, Suite 900

San Francisco  California  94108  U.S.A.
Phone: 415-273-5141 Fax: 415-421-5510



Start Up

Company News
Selexis SA Announces Service Agreement With Swedish Orphan Biovitrum 9/22/2015 9:29:09 AM
Merus And Selexis SA Receive A € 2.1 Million Grant For Single Cell Line Manufacturing Of A Bispecific Antibody Combination To Treat Colorectal Cancer 5/20/2015 10:07:20 AM
Ligand Pharmaceuticals Inc. (LGND) Acquires Rights To More Than 15 Fully-Funded Development Programs From Selexis SA 5/11/2015 8:01:34 AM
Selexis SA Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 1/23/2015 11:34:16 AM
First Selexis SA SUREtechnology Generated Therapeutic Monoclonal Antibody Approved For Market 1/8/2015 11:11:41 AM
Symphogen A/S Licenses The Selexis SA SUREtechnology Expression Platform And Cell Line 12/9/2014 11:29:21 AM
Cook Pharmica LLC And Selexis SA Establish Customized Biologic Drug Development And Manufacturing Services Platform 6/24/2014 10:13:58 AM
Selexis SA To Showcase Revolutionary Advancements In Protein Expression Technologies At BIO 2014 6/5/2014 9:17:00 AM
Opthea Signs Cell Line Development Commercial License Agreement With Selexis SA For Wet AMD Product 1/14/2014 10:40:35 AM
Ligand Pharmaceuticals Inc. (LGND) Buys Rights to Programs From Selexis SA 4/30/2013 7:32:13 AM